{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T15:10:17Z","timestamp":1747321817155,"version":"3.37.3"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Korea Support Committee","award":["CHMTD05083-010"],"award-info":[{"award-number":["CHMTD05083-010"]}]},{"name":"International Vaccine Institute"},{"DOI":"10.13039\/501100017634","name":"LG Electronics","doi-asserted-by":"publisher","award":["CHMTD05083-020"],"award-info":[{"award-number":["CHMTD05083-020"]}],"id":[{"id":"10.13039\/501100017634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021024","name":"Community Chest of Korea","doi-asserted-by":"publisher","award":["CHMTD05083-030"],"award-info":[{"award-number":["CHMTD05083-030"]}],"id":[{"id":"10.13039\/100021024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Cholera is a public health priority in Ethiopia. The Ethiopian National Cholera Plan elaborates a multi-year scheme of oral cholera vaccine (OCV) use. Aligned with this, a preemptive OCV campaign was conducted under our Ethiopia Cholera Control and Prevention project. Here, we present the OCV vaccination outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Method<\/jats:title>\n                  <jats:p>Cholera high-priority hotspots in the Oromia Region, Shashemene Town (ST) and Shashemene Woreda (SW), were selected. Four kebelles (Abosto, Alelu, Arada, and Awasho) in ST and 4 clusters (Faji Gole, Harabate, Toga, and Chabi) in SW were study sites with OCV areas nested within. A total of 40 000 and 60 000 people in ST and SW, respectively, were targeted for a 2-dose OCV (Euvichol-Plus) campaign in 11\u201315 May (first round [R1]) and 27\u201331 May (second round [R2]) 2022. Daily administrative OCV coverage and a coverage survey in 277 randomly selected households were conducted.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The administrative OCV coverage was high: 102.0% for R1 and 100.5% for R2 in ST and 99.1% (R1) and 100.0% (R1) in SW. The coverage survey showed 78.0% (95% confidence interval [CI]: 73.1\u201382.9) of household members with 2-dose OCV and 16.8% (95% CI: 12.4\u201321.3) with no OCV in ST; and 83.1% (95% CI: 79.6\u201386.5) with 2-dose OCV and 11.8% (95% CI: 8.8\u201314.8) with no OCV in SW. The 2-dose coverages in 1\u20134-, 5\u201314-, and \u226515-year age groups were 88.3% (95% CI: 70.6\u201396.1), 88.9% (95% CI: 82.1\u201395.7), and 71.3% (95% CI: 64.2\u201378.3), respectively, in ST and 78.2% (95% CI: 68.8\u201387.7), 91.0% (95% CI: 86.6\u201395.3), and 78.7% (95% CI: 73.2\u201384.1) in SW.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>High 2-dose OCV coverage was achieved. Cholera surveillance is needed to assess the vaccine impact and effectiveness.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciae233","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T16:55:03Z","timestamp":1720803303000},"page":"S33-S42","source":"Crossref","is-referenced-by-count":2,"title":["Coverage of Two-Dose Preemptive Cholera Mass Vaccination Campaign in High-Priority Hotspots in Shashemene, Oromia Region, Ethiopia"],"prefix":"10.1093","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1632-3045","authenticated-orcid":false,"given":"Se Eun","family":"Park","sequence":"first","affiliation":[{"name":"Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute , Seoul , Republic of Korea"},{"name":"Department of Global Health and Disease Control, Yonsei University Graduate School of Public Health , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abel","family":"Gedefaw","sequence":"additional","affiliation":[{"name":"Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute , Seoul , Republic of Korea"},{"name":"College of Medicine and Health Sciences, Hawassa University , Hawassa , Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dejene","family":"Hailu","sequence":"additional","affiliation":[{"name":"Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute , Seoul , Republic of Korea"},{"name":"School of Public Health, College of Medicine and Health Sciences, Hawassa University , Hawassa , Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1728-3627","authenticated-orcid":false,"given":"Yeonji","family":"Jeon","sequence":"additional","affiliation":[{"name":"Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ondari D","family":"Mogeni","sequence":"additional","affiliation":[{"name":"Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geun Hyeog","family":"Jang","sequence":"additional","affiliation":[{"name":"Biostatistics and Data Management (BDM) Department, International Vaccine Institute , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Mukasa","sequence":"additional","affiliation":[{"name":"Biostatistics and Data Management (BDM) Department, International Vaccine Institute , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramzi","family":"Mraidi","sequence":"additional","affiliation":[{"name":"Biostatistics and Data Management (BDM) Department, International Vaccine Institute , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deok Ryun","family":"Kim","sequence":"additional","affiliation":[{"name":"Biostatistics and Data Management (BDM) Department, International Vaccine Institute , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Getahun","sequence":"additional","affiliation":[{"name":"Clinical Trials Directorate, Armauer Hansen Research Institute , Addis Ababa , Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edlawit","family":"Mesfin Getachew","sequence":"additional","affiliation":[{"name":"Clinical Trials Directorate, Armauer Hansen Research Institute , Addis Ababa , Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biruk","family":"Yeshitela","sequence":"additional","affiliation":[{"name":"Bacterial and Viral Disease Research Directorate, Armauer Hansen Research Institute , Addis Ababa , Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuyel","family":"Ayele Abebe","sequence":"additional","affiliation":[{"name":"Data Science Division, Armauer Hansen Research Institute , Addis Ababa , Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukemil","family":"Hussen","sequence":"additional","affiliation":[{"name":"Diseases Surveillance and Response Directorate, Ethiopia Public Health Institute , Addis Ababa , Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeshambel","family":"Worku Demlie","sequence":"additional","affiliation":[{"name":"Diseases Surveillance and Response Directorate, Ethiopia Public Health Institute , Addis Ababa , Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mekonnen","family":"Teferi","sequence":"additional","affiliation":[{"name":"Clinical Trials Directorate, Armauer Hansen Research Institute , Addis Ababa , Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,7,12]]},"reference":[{"issue":"(S1)","key":"2024071515060591500_ciae233-B1","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1093\/cid\/ciae236","article-title":"Retrospective analysis of cholera\/acute watery diarrhea outbreaks in Ethiopia from 2001 to 2023: incidence, case fatality rate, and seasonal and multiyear epidemic patterns","volume":"79","author":"Demlie","year":"2024","journal-title":"Clin Infect Dis"},{"author":"UNOCHA","key":"2024071515060591500_ciae233-B2"},{"issue":"(S1)","key":"2024071515060591500_ciae233-B3","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1093\/cid\/ciae194","article-title":"Comprehensive review on the use of oral cholera vaccine (OCV) in Ethiopia: 2019 to 2023","volume":"79","author":"Edosa","year":"2024","journal-title":"Clin Infect Dis"},{"author":"Ethiopia Ministry of Health","key":"2024071515060591500_ciae233-B4"},{"author":"World Health Organization (WHO)","key":"2024071515060591500_ciae233-B5"},{"key":"2024071515060591500_ciae233-B6","first-page":"477","article-title":"Cholera vaccines: WHO position paper\u2014August 2017","volume":"92","author":"World Health Organization (WHO)","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"year":"2022","author":"World Health Organization (WHO)","key":"2024071515060591500_ciae233-B7"},{"key":"2024071515060591500_ciae233-B8","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1016\/j.vaccine.2018.09.026","article-title":"The Euvichol story\u2014development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships","volume":"36","author":"Odevall","year":"2018","journal-title":"Vaccine"},{"volume-title":"WHO Consultation on oral cholera vaccine (OCV) stockpile strategic framework: potential objectives and possible policy options (WHO\/IVB\/12.05)","year":"2011","author":"World Health Organization (WHO)","key":"2024071515060591500_ciae233-B9"},{"key":"2024071515060591500_ciae233-B10","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMp1402837","article-title":"Embracing oral cholera vaccine\u2014the shifting response to cholera","volume":"370","author":"Pape","year":"2014","journal-title":"N Engl J Med"},{"year":"2022","author":"Em","key":"2024071515060591500_ciae233-B11"},{"key":"2024071515060591500_ciae233-B12","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.1016\/j.vaccine.2015.08.075","article-title":"A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines","volume":"33","author":"Baik","year":"2015","journal-title":"Vaccine"},{"key":"2024071515060591500_ciae233-B13","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa1312680","article-title":"Use of Vibrio cholerae vaccine in an outbreak in Guinea","volume":"370","author":"Luquero","year":"2014","journal-title":"N Engl J Med"},{"key":"2024071515060591500_ciae233-B14","doi-asserted-by":"crossref","first-page":"e2629","DOI":"10.1371\/journal.pntd.0002629","article-title":"Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model","volume":"8","author":"Kar","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"2024071515060591500_ciae233-B15","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1016\/j.vaccine.2015.03.073","article-title":"Effectiveness of an oral cholera vaccine campaign to prevent clinically-significant cholera in Odisha State, India","volume":"33","author":"Wierzba","year":"2015","journal-title":"Vaccine"},{"key":"2024071515060591500_ciae233-B16","doi-asserted-by":"crossref","first-page":"e856","DOI":"10.1016\/S2214-109X(16)30211-X","article-title":"Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study","volume":"4","author":"Azman","year":"2016","journal-title":"Lancet Glob Health"},{"key":"2024071515060591500_ciae233-B17","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.3390\/vaccines9121482","article-title":"Oral cholera vaccine efficacy and effectiveness","volume":"9","author":"Song","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"2024071515060591500_ciae233-B18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1017\/S1049023X17007166","article-title":"A quantitative systematic review and meta-analysis of the effectiveness of oral cholera vaccine as a reactive measure in cholera outbreaks","volume":"33","author":"Schwerdtle","year":"2018","journal-title":"Prehosp Disaster Med"},{"key":"2024071515060591500_ciae233-B19","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/tmi.12641","article-title":"Comparison of immune responses to a killed bivalent whole cell oral cholera vaccine between endemic and less endemic settings","volume":"21","author":"Desai","year":"2016","journal-title":"Trop Medi Int Health"},{"key":"2024071515060591500_ciae233-B20","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.4269\/ajtmh.15-0700","article-title":"Effectiveness of oral cholera vaccine in Haiti: 37-month follow-up","volume":"94","author":"S\u00e9v\u00e8re","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"2024071515060591500_ciae233-B21","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1016\/S2214-109X(15)70015-X","article-title":"Effectiveness of oral cholera vaccine in Haiti","volume":"3","author":"Luquero","year":"2015","journal-title":"Lancet Glob Health"},{"key":"2024071515060591500_ciae233-B22","doi-asserted-by":"crossref","first-page":"e066945","DOI":"10.1136\/bmjopen-2022-066945","article-title":"Effectiveness of two doses of Euvichol-Plus oral cholera vaccine in response to the 2017\/2018 outbreak: a matched case\u2013control study in Lusaka, Zambia","volume":"12","author":"Sialubanje","year":"2022","journal-title":"BMJ Open"},{"key":"2024071515060591500_ciae233-B23","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1080\/21645515.2018.1460295","article-title":"Feasibility and costs of a targeted cholera vaccination campaign in Ethiopia","volume":"14","author":"Teshome","year":"2018","journal-title":"Hum Vaccin Immunother"},{"author":"Global Task Force on Cholera Control","key":"2024071515060591500_ciae233-B24"},{"key":"2024071515060591500_ciae233-B25","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1371\/journal.pmed.0040336","article-title":"Controlling endemic cholera with oral vaccines","volume":"4","author":"Longini","year":"2007","journal-title":"PLoS Med"},{"year":"2018","author":"World Health Organization (WHO)","key":"2024071515060591500_ciae233-B26"},{"author":"Office for National Statistics","key":"2024071515060591500_ciae233-B27"},{"year":"2018","key":"2024071515060591500_ciae233-B28"},{"author":"Hossain","key":"2024071515060591500_ciae233-B29"},{"issue":"(S1)","key":"2024071515060591500_ciae233-B30","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1093\/cid\/ciae232","article-title":"Healthcare seeking behavior and disease perception toward cholera and acute diarrhea among populations living in cholera high-priority hotspots in Shashemene, Ethiopia","volume":"79","author":"Getahun","year":"2024","journal-title":"Clin Infect Dis"},{"author":"WHO Global Task Force on Cholera Control (GTFCC)","key":"2024071515060591500_ciae233-B31"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/79\/Supplement_1\/S33\/58546117\/ciae233.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/79\/Supplement_1\/S33\/58546117\/ciae233.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T16:20:28Z","timestamp":1721060428000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/79\/Supplement_1\/S33\/7712955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,12]]},"references-count":31,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2024,7,12]]},"published-print":{"date-parts":[[2024,7,12]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciae233","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"type":"print","value":"1058-4838"},{"type":"electronic","value":"1537-6591"}],"subject":[],"published-other":{"date-parts":[[2024,7,15]]},"published":{"date-parts":[[2024,7,12]]}}}